Loading company…
Melior Discovery Inc. provides in vivo pharmacology services and validated animal models for drug development.
Founded in 2005 and headquartered in Exton, US, Melior Discovery generates preclinical efficacy data from over 150 validated animal models, mainly rats and mice, for pharmaceutical and biotech clients. Its proprietary platforms include thera TRACE® and opioid TRACE®. The company has completed 7 deals, and on June 24, 2020 it raised USD 1.740 mn in a Series A round. Andrew Reaume is CEO.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in